In Memoriam: Claude Klee, M.D.

Apr 5, 2017

Claude Klee, M.D., a true giant among the many great biochemists at the National Institutes of Health (NIH), died on Monday, April 3, after suffering a heart attack. She was 85 years old.  Learn more...


In Memoriam: Claude Klee, M.D.
Louis Staudt, M.D., Ph.D.

AACR Honors Louis Staudt with Princess Takamatsu Memorial Lectureship

Mar 31, 2017

The American Association for Cancer Research has awarded Louis M. Staudt, Co-Chief of CCR’s Lymphoid Malignancies Branch, its Princess Takamatsu Memorial Lectureship. The lectureship recognizes scientists whose work has had or may have a far-reaching impact on the detection, diagnosis, treatment or prevention of cancer and who embody the dedication of the princess to multinational collaborations. Learn more...

AACR Honors Louis Staudt with Princess Takamatsu Memorial Lectureship

Dr. Figg receives 2017 Tyler Prize for Stimulation of Research Award

Mar 24, 2017

William Figg Sr., Pharm.D., Deputy Chief of the Genitourinary Malignancies Branch, was awarded the 2017 Tyler Prize for Stimulation of Research Award by the American Pharmacists Association (APhA). The Tyler Prize recognizes an individual for encouraging research, directing research or mentoring in the pharmaceutical sciences. One of APhA’s three most prestigious awards, it is only awarded once every three years. Read more...

Steve Rosenberg featured on CBS Sunday Morning

Mar 17, 2017

CBS Sunday Morning recently featured Surgery Branch Chief Steve Rosenberg, M.D., Ph.D. in a special “Beyond Cancer” program. Dr. Rosenberg appeared in a segment on “Immunotherapy: The next frontier in cancer treatment” as the first doctor to successfully cure a patient’s cancer using her own immune system in 1984. “We’ve gotten to the point now where I think we understand why the patients who are successfully treated experience tumor regression,” Dr. Rosenberg said. “And based on that knowledge, I think we’re going to see dramatic progress in the next few years to come.”

In Memoriam: Amar J.S. Klar, Ph.D.

Mar 7, 2017

The Center for Cancer Research mourns the recent death of colleague and friend Amar J.S. Klar, Ph.D.  Dr. Klar was a much-liked and respected member of the NCI community as part of the Gene Regulation and Chromosome Biology Laboratory since 1988.  Read more...

Chuan Wu joins CCR as a Stadtman tenure track investigator

Feb 27, 2017

Chuan Wu, M.D., Ph.D. has joined the Experimental Immunology Branch (EIB) as a Stadtman tenure track Investigator.  Dr. Wu's research focuses on differentiation of autoreactive T cells and the mechanism of neuro-immune crosstalk in autoimmunity.  Learn more...

Conquer Cancer Foundation honors Farhad Fakhrejahani with a Genitourinary Cancers Symposium Merit Award

Feb 23, 2017

Farhad Fakhrejahani, M.D., Medical Oncology Fellow, has received a 2017 Conquer Cancer Foundation Merit Award. The award honors early career oncologists’ research activities and recognizes young scientists who have made a significant impact with their research. The award stipend assisted Dr. Fakhrejahani with presenting his research, "Avelumab in metastatic castration-resistant prostate cancer," at the Genitourinary Cancers Symposium in Orlando, Florida, which was held February 16-18.

Sandra Wolin joins CCR as Chief, RNA Biology Laboratory

Feb 21, 2017

Sandra Wolin, M.D., Ph.D., has joined CCR as the inaugural Chief of the newly established RNA Biology Laboratory on the Frederick campus. She will continue the world-class research program she established at Yale and will play a leading role in developing an integrated program in RNA biology in CCR. Learn more...

Terry Fry inducted into American Society of Clinical Investigation

Feb 14, 2017

Terry Fry, M.D., Investigator in the Pediatric Oncology Branch, is a newly elected member of The American Society for Clinical Investigation (ASCI), an honor society of physician-scientists who translate laboratory research to clinical practice. Dr. Fry's research is focused on the preclinical and clinical development of cell-based immunotherapy for pediatric leukemias. He is actively engaged in national cooperative groups involved in improving outcomes following hematopoietic stem cell transplantation for pediatric malignancies. More recently, his efforts have also focused on the use of genetically modified T cell therapy for acute lymphoblastic leukemia. He is one of 64 new members of the ASCI.  Learn more...

Dr. Zhengping Zhuang appointed as senior investigator

Jan 27, 2017

Zhengping Zhuang, M.D., Ph.D., has joined the Neuro-Oncology Branch (NOB) as a senior investigator.  Dr. Zhuang's research focuses on functional genomics and molecular signaling in central nervous system tumors to identify the critical genes and molecules in cancer formation and progression.  Learn more...